跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 4,885 条关于
“MDK”
全部
4,885
临床试验
3,764
药物
785
机构
66
资讯
270
3个月前
Cross-Species Single-Cell Atlas Reveals Conserved and Divergent Programs in Mammalian Fetal Ovarian Development
3个月前
Transplanted Neural Progenitor Cells Survive One Year in Retinitis Pigmentosa Patients, Phase 1/2a Trial Shows
去年
MD Anderson Research Highlights: Modified NRF2 Activator, Canakinumab in MDS, and More
去年
MD Anderson Highlights: Modified NRF2 Activator Reverses Chronic Pain, Canakinumab Shows Promise in MDS Subgroup
去年
Leading MDS Expert Dr. Garcia-Manero Reflects on 25 Years of Mentorship and Innovation at MD Anderson
去年
Tamibarotene Fails to Meet Primary Endpoint in SELECT-MDS-1 Trial for Higher-Risk Myelodysplastic Syndrome
2年前
Advancements in Higher-Risk MDS Treatment Strategies Explored
2年前
Imetelstat Shows Durable Transfusion Independence in Lower-Risk MDS
去年
Syros' Tamibarotene Fails Phase III Trial in MDS Patients
去年
Xenon Pharmaceuticals Advances Azetukalner Program for Epilepsy and MDD
第 1 页,共 27 页
上一页
下一页